Chambers Michael Andrew

Average Profitability
11.83%
Insider Buys Quantity
5
Insider Buys Sum
$16.65M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Chambers Michael Andrew

According to the SEC Form 4 filings, Chambers Michael Andrew, being in a position of

  1. director at Sarepta Therapeutics, Inc.,
    оver the last 12 months, has bought 37038 shares for $4.96M, and sold 0 shares,
    over all time since 2022-08-19, has bought 145680 shares for $16.65M, and sold 0 shares.

The largest purchase of all time was on 2024-08-16 and amounted to 37038 shares of Sarepta Therapeutics, Inc. for $4.96M.

Biography of Chambers Michael Andrew

No biography is available at this moment.

2024-08-16PurchaseSarepta Therapeutics, Inc.
SRPT
director
37,038
0.0404%
$133.80$4.96M0%
2023-08-14PurchaseSarepta Therapeutics, Inc.
SRPT
director
9,979
0.0104%
$109.47$1.09M+7.21%
2023-08-11PurchaseSarepta Therapeutics, Inc.
SRPT
director
23,686
0.0254%
$108.05$2.56M+11.44%
2023-08-10PurchaseSarepta Therapeutics, Inc.
SRPT
director
34,867
0.0374%
$106.15$3.7M+13.5%
2022-08-19PurchaseSarepta Therapeutics, Inc.
SRPT
40,110
0.0459%
$108.20$4.34M+11.83%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.